Recruiting studies: Kit Gene Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (G
Phase 2 · 13 location(s) · Centre Leon Berard · NCT05009927 An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Phase N/A · 1 location(s) · Blueprint Medicines Corporation · NCT07264959 Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
Phase 2 · 12 location(s) · Children's Hospital of Soochow University · NCT06316960 Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation
Phase N/A · 1 location(s) · LifeOS Genomics Corporation · NCT06573073 Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Strom
Phase 2 · 1 location(s) · Jian Li · NCT07559864 A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
Phase 1/Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07028073 Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
Phase N/A · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07562542 A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Phase N/A · 8 location(s) · Blueprint Medicines Corporation · NCT07255638 Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Phase N/A · 19 location(s) · Blueprint Medicines Corporation · NCT07143669 DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit
NA · 1 location(s) · QIAGEN Gaithersburg, Inc · NCT06645236 Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04557969

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.